ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $524,569 | -24.3% | 1,067 | -40.0% | 0.24% | -23.3% |
| Q2 2023 | $692,940 | -20.3% | 1,778 | -23.8% | 0.32% | -55.2% |
| Q1 2023 | $869,229 | -1.6% | 2,333 | 0.0% | 0.71% | +34.9% |
| Q4 2022 | $883,810 | +8.0% | 2,333 | +0.6% | 0.52% | +12.4% |
| Q3 2022 | $818,000 | +0.2% | 2,318 | +7.7% | 0.47% | -5.3% |
| Q2 2022 | $816,000 | -15.4% | 2,153 | -29.7% | 0.49% | -19.7% |
| Q1 2022 | $965,000 | -50.5% | 3,061 | -45.0% | 0.61% | -60.4% |
| Q4 2021 | $1,948,000 | +73.9% | 5,562 | +50.0% | 1.55% | +109.3% |
| Q3 2021 | $1,120,000 | +27.4% | 3,707 | +27.0% | 0.74% | +18.9% |
| Q2 2021 | $879,000 | +35.4% | 2,919 | +23.8% | 0.62% | +29.3% |
| Q1 2021 | $649,000 | -20.7% | 2,357 | -15.3% | 0.48% | -7.7% |
| Q4 2020 | $818,000 | +51.5% | 2,783 | +35.2% | 0.52% | +32.5% |
| Q3 2020 | $540,000 | +28.0% | 2,058 | +9.9% | 0.39% | +12.9% |
| Q2 2020 | $422,000 | – | 1,872 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |